The focus of this learning activity is to offer an opportunity for current and prospective members of interprofessional healthcare bioethics committees to gain introductory knowledge of healthcare-related ethical issues.
Richard K. Saunders, MD
Staff Physician, Hospital Medicine^; Instructor in Medicine*
^ Dartmouth Hitchcock Medical Center, Lebanon, NH
* Geisel School of Medicine, Hanover, NH
At the conclusion of this learning activity, (at least 75% of) participants will be able to be able to describe the principles of informed consent, dissent, and assent in medical decision making.
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- Carrese JA. HCEC pearls and pitfalls: suggested do's and don't's for healthcare ethics consultants. J Clin Ethics 2012; 23:234-40.
- Fletcher J, Siegler M. What are the goals of ethics consultation? A Consensus Statement. J Clinical Ethics 1996; 7:122-126.
- Fox E, Myers S, Pearlman R. Ethics Consultation in United States Hospitals: A National Survey. Am J Bioethics 2007; 7(2) 13-25.
- Fox E. The Road to Certification for Clinical Ethics Consultants: Finding Our Bearings. Am J Bioethics 2016; 16(3):33-37.
- Kelly DF, Hoyt JW. Ethics Consultation. Medical Ethics. 1996; 12(1) 49-70.